Jason Gardner - Title: President and Chief Executive Officer, Director at Dianthus Therapeutics, Inc. /DE/

Issuer-level insider activity

Role: Title: President and Chief Executive Officer, Director
Issuer ticker: DNTH on Nasdaq
Entity type: Individual
Source filing history: Open source filing history

No buys or sells have been reported by Jason Gardner since 05 Sep 2025

Reported holdings for Jason Gardner in Dianthus Therapeutics, Inc. /DE/

Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class: Common Stock
Shares / value: 359,092
Estimated value: $4,309,104
Report date: 30 Nov 2022
Price: $12.00
Ownership: By P.S. Gardner Irrevocable Trust

Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class: Common Stock
Shares / value: 292,990
Estimated value: $3,515,880
Report date: 30 Nov 2022
Price: $12.00
Ownership: By J.P. Gardner Irrevocable Trust

Form 4 holding Title: President and Chief Executive Officer, Director

Magenta Therapeutics, Inc.

Security class: Common Stock
Shares / value: 292,872
Estimated value: $3,514,464
Report date: 30 Nov 2022
Price: $12.00
Ownership: Direct

Transaction history for Jason Gardner in Dianthus Therapeutics, Inc. /DE/

Sym	Class	Transaction	%	SEC-reported value	SEC-reported price	Shares	Shares after	Date	Ownership

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .